Nordic Issuing

Ongoing case

Clinical Laserthermia Systems AB

Back to all cases

Clinical Laserthermia Systems AB

23 Aug - 6 Sep 2022Rights issue

At CLS, they aim at getting doctors as close as possible to the clinical problem and provide the means needed for solving it – without causing another. They do this by providing precise tools for image-guided laser-mediated thermal ablations.

Thermal ablation is used for treatment and removal of diseased or abnormal soft tissues, such as malignant tumors (cancer) or epileptogenic foci. The procedure is minimally invasive and can therefore be offered also to patients that are considered inoperable in view of traditional open surgery.

Read more on the company's website

The offer in summary

Record date: 18 August 2022

Subscription period: 23 August - 6 September 2022

Subscription rights: Anyone who were shareholder in the Company on the record date of August 18, 2022 has a preferential right to subscribe for units in the rights issue in relation to previous holdings, whereby one (1) existing share gives one (1) unit rights. Two (2) unit rights entitle to subscribe for one (1) new unit. One (1) unit consists of two (2) new B-shares and one (1) warrant of series TO 5.

Subscription price: 2.00 SEK per unit

The offer: 34 653 275 units which corresponds to ca 69 MSEK

Trading with unit rights: 23 August - 1 September 2022

Marketplace: Nasdaq First North Growth Market

Financial advisor: Sedermera Corporate Finance

Subscribe directly at Avanza here

Subscribe directly at Nordnet here


Due to restrictions in applicable law in the United States, Canada, Australia, Hong Kong, Singapore, South Africa, Switzerland, New Zealand, Japan, Russia, Belarus or other countries where participation requires further prospectuses, registrations or actions other than those under Swedish law, the offer to subscribe for securities in this offer is not directed at persons or others with registered address in any of these countries.